Advertisement

Autoimmunenzephalitiden

  • Franz BlaesEmail author
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Enzephalitiden sind eine Gruppe neurologischer Erkrankungen, die sich akut bis subakut durch eine Entzündung des Gehirns entwickeln. Bis vor einigen Jahren wurden die meisten dieser Erkrankungen als erregerbedingt angesehen, obwohl häufig kein Erreger nachweisbar war. Durch die Entdeckung verschiedener Autoantikörper gegen neuronale Rezeptoren, synaptische Proteine oder Ionenkanäle konnte in den letzten 10–15 Jahren eine Gruppe autoimmuner und weitgehend antikörpervermittelter Enzephalitiden identifiziert werden. Während Enzephalitiden mit typischen antineuronalen Antikörpern gegen intrazelluläre onkoneuronale Antigene, wie Anti-Hu oder Anti-Ma fast immer paraneoplastisch sind, liegt bei den hier beschriebenen Autoimmunenzephalitiden nur in einem Teil der Fälle ein Tumorleiden zugrunde. Diese autoimmunen Enzephalitiden werden in diesem Kapitel näher dargestellt.

Literatur

Zitierte Literatur

  1. Bien CG, Elger CE (2007) Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav 10(4):529–538CrossRefPubMedGoogle Scholar
  2. Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J (2013) Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 73(1):120–128CrossRefPubMedGoogle Scholar
  3. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B (2006) Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 63(2):197–202CrossRefPubMedGoogle Scholar
  4. Coban A, Ismail Kucukali C, Bilgic B, Yalcinkaya N, Haytural H, Ulusoy C, Turan S, Cakir S, Ucok A, Unubol H, Hanagasi HA, Gurvit H, Tuzun E (2014) Evaluation of incidence and clinical features of antibody-associated autoimmune encephalitis mimicking dementia. Behav Neurol 935379Google Scholar
  5. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1):25–36CrossRefPubMedPubMedCentralGoogle Scholar
  6. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098CrossRefPubMedPubMedCentralGoogle Scholar
  7. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1):63–74CrossRefPubMedPubMedCentralGoogle Scholar
  8. De Bruijn MA, Titulaer MJ (2016) Anti-NMDAR encephalitis and other glutamate and GABA receptor antibody encephalopathies. Handb Clin Neurol 133:199–217CrossRefPubMedGoogle Scholar
  9. Flanagan EP, Drubach DA, Boeve BF (2016) Autoimmune dementia and encephalopathy. Handb Clin Neurol 133:247–267CrossRefPubMedGoogle Scholar
  10. Gresa-Arribas N, Planaguma J, Petit-Pedrol M, Kawachi I, Katada S, Glaser CA, Simabukuro MM, Armangue T, Martinez-Hernandez E, Graus F, Dalmau J (2016) Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development. Neurology 86(24):2235–2242CrossRefPubMedPubMedCentralGoogle Scholar
  11. Hoftberger R, Titulaer MJ, Sabater L, Dome B, Rozsas A, Hegedus B, Hoda MA, Laszlo V, Ankersmit HJ, Harms L, Boyero S, de Felipe A, Saiz A, Dalmau J, Graus F (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81(17):1500–1506CrossRefPubMedPubMedCentralGoogle Scholar
  12. Iizuka T, Leite MI, Lang B, Waters P, Urano Y, Miyakawa S, Hamada J, Sakai F, Mochizuki H, Vincent A (2012) Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations. J Neurol 259(8):1566–1573CrossRefPubMedGoogle Scholar
  13. Iorio R, Assenza G, Tombini M, Colicchio G, Della Marca G, Benvenga A, Damato V, Rossini PM, Vollono C, Plantone D, Marti A, Batocchi AP, Evoli A (2015) The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy. Eur J Neurol 22(1):70–78CrossRefPubMedGoogle Scholar
  14. Irani SR, Vincent A (2016) Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurol 133:185–197CrossRefPubMedGoogle Scholar
  15. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010a) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133(9):2734–2748CrossRefPubMedPubMedCentralGoogle Scholar
  16. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010b) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133(Pt 6):1655–1667CrossRefPubMedPubMedCentralGoogle Scholar
  17. Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, Schott JM, Armstrong RJ, A SZ, Bleasel A, Somerville ER, Smith SM, Vincent A (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69(5):892–900CrossRefPubMedGoogle Scholar
  18. Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72(2):241–255CrossRefPubMedGoogle Scholar
  19. Irani SR, Stagg CJ, Schott JM, Rosenthal CR, Schneider SA, Pettingill P, Pettingill R, Waters P, Thomas A, Voets NL, Cardoso MJ, Cash DM, Manning EN, Lang B, Smith SJ, Vincent A, Johnson MR (2013) Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 136(Pt 10):3151–3162CrossRefPubMedGoogle Scholar
  20. Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD (2014) Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. JAMA Neurol 71(7):896–900CrossRefPubMedPubMedCentralGoogle Scholar
  21. Joubert B, Saint-Martin M, Noraz N, Picard G, Rogemond V, Ducray F, Desestret V, Psimaras D, Delattre JY, Antoine JC, Honnorat J (2016) Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures. JAMA Neurol 73(9):1115–1124CrossRefPubMedGoogle Scholar
  22. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Mata S, Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R, Graus F, Lynch DR, Balice-Gordon R, Dalmau J (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65(4):424–434CrossRefPubMedPubMedCentralGoogle Scholar
  23. Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9(8):776–785CrossRefPubMedPubMedCentralGoogle Scholar
  24. Lancaster E (2016) The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 12(1):1–13CrossRefPubMedGoogle Scholar
  25. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T, Guzman M, Graus F, Moss SJ, Balice-Gordon R, Dalmau J (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9(1):67–76CrossRefPubMedGoogle Scholar
  26. Lancaster E, Leypoldt F, Titulaer MJ, Honnorat J, Waters PJ, Reindl M, Hoftberger R (2015) Immunoglobulin G antibodies to the N-Methyl-D-aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responses. Ann Neurol 77(1):183CrossRefPubMedGoogle Scholar
  27. Laurent C, Capron J, Quillerou B, Thomas G, Alamowitch S, Fain O, Mekinian A (2016) Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): characteristics, treatment and outcome in 251 cases from the literature. Autoimmun Rev 15(12):1129–1133CrossRefPubMedGoogle Scholar
  28. Martinez-Hernandez E, Arino H, McKeon A, Iizuka T, Titulaer MJ, Simabukuro MM, Lancaster E, Petit-Pedrol M, Planaguma J, Blanco Y, Harvey RJ, Saiz A, Graus F, Dalmau J (2016) Clinical and immunologic investigations in patients with stiff-person spectrum disorder. JAMA Neurol 73(6):714–720CrossRefPubMedPubMedCentralGoogle Scholar
  29. Mikasova L, De Rossi P, Bouchet D, Georges F, Rogemond V, Didelot A, Meissirel C, Honnorat J, Groc L (2012) Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 135(Pt 5):1606–1621CrossRefPubMedGoogle Scholar
  30. Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, McCracken L, Martinez-Hernandez E, Mason WP, Kruer MC, Ritacco DG, Grisold W, Meaney BF, Alcala C, Sillevis-Smitt P, Titulaer MJ, Balice-Gordon R, Graus F, Dalmau J (2014) Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 13(3):276–286CrossRefPubMedPubMedCentralGoogle Scholar
  31. Pettingill P, Kramer HB, Coebergh JA, Pettingill R, Maxwell S, Nibber A, Malaspina A, Jacob A, Irani SR, Buckley C, Beeson D, Lang B, Waters P, Vincent A (2015) Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization. Neurology 84(12):1233–1241CrossRefPubMedPubMedCentralGoogle Scholar
  32. Planaguma J, Leypoldt F, Mannara F, Gutierrez-Cuesta J, Martin-Garcia E, Aguilar E, Titulaer MJ, Petit-Pedrol M, Jain A, Balice-Gordon R, Lakadamyali M, Graus F, Maldonado R, Dalmau J (2015) Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain 138(Pt 1):94–109CrossRefPubMedGoogle Scholar
  33. Pruss H, Finke C, Holtje M, Hofmann J, Klingbeil C, Probst C, Borowski K, Ahnert-Hilger G, Harms L, Schwab JM, Ploner CJ, Komorowski L, Stoecker W, Dalmau J, Wandinger KP (2012) N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72(6):902–911CrossRefPubMedPubMedCentralGoogle Scholar
  34. Rocamora R, Becerra JL, Fossas P, Gomez M, Vivanco-Hidalgo RM, Mauri JA, Molins A (2014) Pilomotor seizures: an autonomic semiology of limbic encephalitis? Seizure 23(8):670–673CrossRefPubMedGoogle Scholar
  35. Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, Vilaseca I, Iranzo A, Santamaria J, Dalmau J, Graus F (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13(6):575–586CrossRefPubMedPubMedCentralGoogle Scholar
  36. Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D (2012) Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79(11):1094–1100CrossRefPubMedPubMedCentralGoogle Scholar
  37. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322(22):1555–1560CrossRefPubMedGoogle Scholar
  38. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S (2004) Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62(7):1177–1182CrossRefPubMedGoogle Scholar
  39. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2):157–165CrossRefPubMedPubMedCentralGoogle Scholar
  40. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127(Pt 3):701–712CrossRefPubMedGoogle Scholar

Weiterführende Literatur

  1. Höftberger R (2015) Neuroimmunology: an expanding frontier in autoimmunity. Front Immunol 6:206CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  1. 1.Neurologische KlinikKlinikum OberbergGummersbachDeutschland

Personalised recommendations